Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99-Reference-Cited by-同舟云学术

Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99

Published:2018-01-31 Issue:16 Volume:37 Page:2181-2196
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Çelik Haydar,Sciandra Marika,Flashner Bess,Gelmez Elif,Kayraklıoğlu Neslihan,Allegakoen David V.,Petro Jeff R.,Conn Erin J.,Hour Sarah,Han Jenny,Oktay Lalehan,Tiwari Purushottam B.,Hayran Mutlu,Harris Brent T.,Manara Maria Cristina,Toretsky Jeffrey A.,Scotlandi Katia,Üren Aykut

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-017-0080-4.pdf

Reference59 articles.

1. Kovar H. Ewing’s sarcoma and peripheral primitive neuroectodermal tumors after their genetic union. Curr Opin Oncol. 1998;10:334–42.

2. Arndt CA, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med. 1999;341:342–52.

3. Kovar H, Amatruda J, Brunet E, Burdach S, Cidre-Aranaz F, de Alava E, et al. The second European interdisciplinary Ewing sarcoma research summit—a joint effort to deconstructing the multiple layers of a complex disease. Oncotarget. 2016;7:8613–24.

4. Lawlor ER, Sorensen PH. Twenty years on: What do we really know about ewing sarcoma and what is the path forward? Crit Rev Oncog. 2015;20:155–71.

5. Gaspar N, Hawkins DS, Dirksen U, Lewis IJ, Ferrari S, Le Deley MC, et al. Ewing sarcoma: Current management and future approaches through collaboration. J Clin Oncol. 2015;33:3036–46.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in CAR‐T cell therapy for acute myeloid leukaemia;Journal of Cellular and Molecular Medicine;2024-05

2. In VivoCytotoxic, Genotoxic and Radiosensitizing Effects of Clofarabine;In Vivo;2024

3. A Bayesian active learning platform for scalable combination drug screens;2023-12-19

4. Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability;European Journal of Medicinal Chemistry;2023-05

5. Current Challenges and Potential Strategies for Designing a New Generation of Chimeric Antigen Receptor-T cells with High Anti-tumor Activity in Solid Tumors;Current Tissue Microenvironment Reports;2023-03-21